CN1CCN(Cn2nc(-c3ccccc3)n(/N=C/c3ccc(-c4ccc(Cl)cc4Cl)o3)c2=S)CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?